AFT Pharmaceuticals outlines shareholder value focus in 2025 AGM
At its annual shareholders meeting in Auckland today, AFT Pharmaceuticals (ASX:AFP) laid out its plans to...
Chariot to acquire majority stake in Nigerian lithium portfolio
Chariot Corporation (ASX:CC9) has acquired a 66.7% interest in a "highly prospective" hard rock lithium portfolio...
Final stretch in golden acquisition for Haranga Resources
Haranga Resources (ASX:HAR) is on the verge of becoming the "proud new owners" of a 286,000...
‘Big tick’: Viridis positions for global leadership with Colossus pre-feasibility study
Viridis Mining and Minerals (ASX:VMM) has this week wrapped up a pre-feasibility study for its flagship...
AGC solidifies strong hold on South Cobar Basin with new tenement
Australian Gold and Copper (ASX:AGC) has become the dominant titleholder across the South Cobar Basin, securing...
Neurizon significantly advances NUZ-001, enters global licensing agreement
Neurizon Therapeutics (ASX:NUZ) has this week arrived at its next "watershed moment" as it looks to...
The Calmer Co FY25 revenue hits $8 million, up 86% on FY24
The Calmer Co (ASX:CCO) has wrapped up FY25 with preliminary unaudited revenue surpassing $8 million, which...
Redcastle Resources continues ‘breakout year’ with MRE update
Redcastle Resources has been enjoying a "breakout year" and now the good times are rolling on...
AFT Pharmaceuticals launches Combogesic IV in Canada
AFT Pharmaceuticals has "lots of exciting things happening" as FY26 begins, not least Combogesic IV launching...
Paradigm Biopharmaceuticals makes key acquisition moving into FY26
Paradigm Biopharmaceutical (ASX: PAR) has opened the purse strings to pick up Proteobioactives Pty Ltd, which...